baber/WOPTO huggingface dataset:
Patent JP-3285577-B2 (JP)
IPC: C07K16/00
Filed: 1992-07-29
Granted: 2002-05-27
Abstract: Immunoassay methods and reagents for the specific quantification of imipramine or desipramine in a test sample are disclosed. The measurement of imipramine or desipramine is accomplished in a specific immunoassay employing antibodies prepared with imipramine or desipramine derivatives of the Formula III:    <IMAGE>  III  wherein P is an immunogenic carrier material, X is two heteroatoms, Y is a linking group comprising from 1 to 6 carbon atoms and P is an immunogenic carrier material, and wherein for imipramine, R is CH3, and for desipramine, R is H. The present invention also describes the synthesis of unique labeled reagents of the structure of the Formula IV:    <IMAGE>  IV  wherein Z is a linking group comprising 1 to 4 carbon atoms and 0 to 2 heteroatoms and Q is a detectable moiety, preferably fluorescein or a fluorescein derivative, and wherein for imipramine, R1 is CH3, and for desipramine, R1 is H.
Patent JP-2807012-B2 (JP)
IPC: G01N29/34
Filed: 1989-02-22
Granted: 1998-09-30
Abstract: An ultrasonic sound echography technique is disclosed in which echo-masked zones of the workpiece are reduced by utilizing particular orientations of the beam of ultrasonic sound relative to formations in the workpiece. Echo-masked zones result from formations in the workpiece which reflect the ultrasonic sound waves back to the probe and therefore mask the much smaller echoes from anomalies, if any, in the workpiece. Instead of the conventional orientation of the beam, in which the scanning plane in which the beam lies is oriented perpendicularly to formations, the scanning planes are selected so as to be non-perpendicular with respect to such formations and to minimize the amount of masking echoes from the formations.
Patent JP-3926850-B2 (JP)
IPC: B29C70/08
Filed: 1997-07-14
Granted: 2007-06-06
Abstract: An elastic laminate structure is provided which is formed from at least one fabric layer and an open cell mesh having first and second strands. The laminate structure is formed such that the first strands are integrally bonded to the first fabric layer. The integrally bonded first strands both penetrate the first fabric layer and bond mechanically and/or chemically to the fibers of the first fabric layer. In addition, the first strands are deformed such that they are substantially flat in shape and substantially coplanar with the fabric layer. The elastic second strands have a substantially elliptical shape. The integral bonding of the first strands and the deformed shape of the first strands and the second strands provides an elastic laminate structure which can be worn about the body without irritation or other discomfort.
Patent JP-3183885-B2 (JP)
IPC: D21H17/06
Filed: 1992-10-19
Granted: 2001-07-09
Abstract: Tissue paper webs useful in the manufacture of soft, absorbent products such as paper towels, napkins, and facial tissues, and processes for making the webs. The tissue paper webs comprise papermaking fibers, a biodegradable quaternary ammonium compound, a polyhydroxy plasticizer, and a permanent wet strength resin. The process comprises a first step of forming an aqueous papermaking furnish from the above-mentioned components. The second and third steps in the basic process are the deposition of the papermaking furnish onto a foraminous surface such as a Fourdrinier wire and removal of the water from the deposited furnish. An alternate process involves the use of the furnish containing the aforementioned components in a papermaking process which will produce a pattern densified fibrous web having a relatively high bulk field of relatively low fiber density in a patterned array of spaced zones of relatively high fiber density.
Patent JP-2559997-B2 (JP)
Inventor: SHIRAA AUGUSUTO
IPC: C08L83/14
Filed: 1992-11-13
Granted: 1996-12-04
Abstract: Tin cpd.-contg. materials (I) are claimed as one of the two components of room temp.-vulcanising (RTV) silicone elastomer systems (II), contg. (a) triorganosiloxy-terminated diorganopolysiloxane in which the organic gps. are opt. halogenated hydrocarbyl gps., (b) reaction prod. of diorganotin diacylate (II) with disila-alkane contg. at least 2 opt. alkoxy-substd. hydrocarbyl gps. attached to Si via oxygen (III) or an oligomer of (III), (c) organo-Si cpd. with at least one Si-C linked amino or imino gp., opt. (d) filler and opt. (e) disila-alkane and/or silane with at least 3, Si-O linked, opt. alkoxy-substd. hydrocarbyl gps., or an oligomer thereof. Specifically the Si-O-C linked organic gps. in components, (b), (c) and (e) are identical.
Patent JP-H0776182-B2 (JP)
IPC: A61K51/04
Filed: 1990-03-20
Abstract: A myocardial imaging agent for humans is a technetium(III) complex ligated in the planar positions by a tetradentate ligand such as (acac)2en and in the axial positions by an ether containing phosphine ligand such as tris(3-methoxy-1-propyl)phosphine. The agent exhibits extremely rapid blood clearance after injection into a human and has a sufficiently high heart/liver and heart/lung ratios to provide effective myocardial images.
Patent JP-3729847-B2 (JP)
IPC: C07C11/00
Filed: 1994-01-07
Granted: 2005-12-21
Abstract: The present invention relates to calcipotriol hydrate-a new crystalline form of calcipotriol-with superior technical properties and with superior stability.
Patent JP-3611856-B2 (JP)
IPC: C12N5/08
Filed: 1995-02-06
Granted: 2005-01-19
Abstract: Composition comprising two pathogenic and/or infective agents associated with multiple sclerosis, namely a first agent which consists of a human virus possessing reverse transcriptase activity and related to a family of endogenous retroviral elements, or a variant of said virus, and a second agent, or a variant of said second agent, these two pathogenic and/or infective agents originating from the same viral strain chosen from the strains designated, respectively, POL-2 deposited with the ECACC on Jul. 22 1992 under Accession Number V92072202 and MS7PG deposited with the ECACC on Jan. 8 1993 under Accession Number V93010816, and from their variant strains.
Patent JP-4072869-B2 (JP)
IPC: H04R1/34
Filed: 1996-11-20
Granted: 2008-04-09
Abstract: An acoustic reflector is disclosed, which is formed from the surface generated by an ellipse rotated about 180 DEG  about a line passing through one of the focal points of the ellipse, where this line of rotation intersects the major axis at an acute angle. A transducer placed at the focal point on the line of revolution will, when energized, generate waves that will be reflected from the surface back through the arc of second focal points of the generating ellipse.
Patent AU-2001251732-B2 (AU)
Title: Modular beverage dispenser
Inventor: CREDLE WILLIAM S JR
IPC: B67D1/00
Filed: 2001-03-21
Granted: 2004-09-16
Abstract: A modular mounting block for a beverage dispenser. The modular mounting block includes a number of pump compartments and a number of dispensing valve compartments formed integrally within the block.
Patent AU-2001272530-B2 (AU)
Title: Dihydroxypyrimidine carboxylic acids as viral polymerase inhibitors
Inventor: GARDELLI CRISTINA
IPC: C07D409/14
Filed: 2001-07-11
Granted: 2006-08-03
Abstract: A class of 2-aryl-4,5-dihydroxy-6-carboxypyrimidines of formula (I): wherein Ar is an optionally substituted aryl or heterocyclicgroup; as well as compounds of formula (I) which are derivatized at one or more of the 4-hydroxy, 5-hydroxy or 6-carboxy groups; and tautomers thereof, and pharmaceutically acceptable salts or esters thereof; and inhibitors of viral polymerases, especially the hepatitis C virus (HCV) polymerase enzyme
Patent AU-2001288478-B2 (AU)
Title: Plant polynucleotides encoding prenyl proteases
Inventor: HENKES STEFAN
IPC: C12N15/55
Filed: 2001-08-27
Granted: 2006-11-02
Abstract: The present invention provides novel polynucleotides encoding plant prenyl protease polypeptides, fragments and homologs thereof. Also provided arc vectors, host cells, antibodies, and recombinant methods for producing said polypeptides. The invention further provides novel polynucleotides encoding plant promoters, polypeptides, fragments and homologs thereof. The invention further relates to methods of applying these novel plant polypeptides to the identification, prevention, and/or conferment of resistence to various plant diseases and/or disorders, particularly drought resistence.
Patent AU-2002231703-B2 (AU)
Title: Pharmaceutical formulation comprising cyclosporin and use thereof
Inventor: JAHN KONSTANZE
IPC: A61P17/02
Filed: 2001-12-14
Granted: 2007-03-29
Abstract: The present invention relates to a pharmaceutical formulation in colloidal form for topical application for the therapy and prophylaxis of pathological changes of the skin and/or integumentary structures of the skin and/or mucous membranes, including mucous membranes of the digestive tract, uro-genital tract and bronchial system and/or conjunctiva, containing a lipophilic phase in a quantity of 1-10% by weight, a mixture of surfactant and co-surfactant in a quantity of 1-50% by weight, a hydrophilic phase in a quantity of 40-80% by weight and, as active ingredient, cyclosporin and/or derivatives thereof in a concentration of 0.1-20% by weight.
Patent AU-2002238550-B2 (AU)
Title: Box with hinged lid
Inventor: LUTZIG BODO-WERNER
IPC: B65D85/10
Filed: 2002-02-13
Granted: 2007-11-22
Abstract: A container blank is provided for a box with a hinged lid wherein the lid is reliably closed by way of an enlarged collar section. The closure of the box can be aided by surfaces formed on the container blank such that when folded into a box, the surfaces of the closure can provide resistance to the lid opening. Additionally, a lid portion of the container blank can optionally be provided with an embossed section.
Patent AU-2002302063-B2 (AU)
Title: Seam enhancements for seamed papermaker's fabrics
Inventor: KORNETT GLENN J
IPC: D21F1/00
Filed: 2002-11-20
Granted: 2005-12-01
Abstract: An on-machine-seamable papermaker's fabric produced by modified endless weaving includes machine-direction (MD) and first cross-machine-direction (CD) yarns. The MD yarns weave continuously back and forth between the two widthwise edges of the fabric, each time forming a seaming loop at one of the two widthwise edges. The MD and first CD yarns are interwoven with one another in a first weave pattern. The fabric also includes systems of second and third CD yarns. The second CD yarns are interwoven with the MD yarns along one of the two widthwise edges of the fabric between the system of first CD yarns and the seaming loops in a second weave pattern which may be different from the first weave pattern. Likewise, the third CD yarns are interwoven with the MD yarns along the other of the two widthwise edges of the fabric between the system of first CD yarns and the seaming loops in a third weave pattern which may be different from the first weave pattern. The second and third weave patterns may be the same as or different from one another. The second and third CD yarns may make the compressibility and permeability characteristics of the seam regions like those of the rest of the fabric, or may improve the stability, uniformity and orientation of the seaming loops at the two ends of the fabric.
Patent AU-2002305066-B2 (AU)
Title: Methods for increasing analgesic potency and attenuating adverse excitatory effects of bimodally-acting opioid agonists by inhibiting GM1-ganglioside
Inventor: SHEN KE-FEI
IPC: A61P25/20
Filed: 2002-03-19
Granted: 2007-12-20
Abstract: The present invention provides a method for increasing analgesic potency of a bimodally-acting opioid agonist in a subject, by inhibiting GM1-ganglioside in nociceptive neurons. The present invention further provides a method for treating pain in a subject in need of treatment thereof. Also provided in the present invention is a method for treating chronic pain in a subject in need of treatment thereof. Additionally, the present invention provides a method for treating tolerance to or an addiction to a bimodally-acting opioid agonist in a subject in need of treatment thereof. Finally, the present invention provides a pharmaceutical composition of analgesic agents and a pharmaceutically-acceptable carrier.
Patent AU-2002327744-B2 (AU)
Title: Orally administered liquid compositions comprising guaifenesin and a polyoxyalkylene block copolymer
Inventor: MULLET BENOIT MAURICE
IPC: A61K31/09
Filed: 2002-09-27
Granted: 2006-10-12
Abstract: The present invention is an orally administered liquid pharmaceutical composition that demonstrates excellent physical stability while delivering concentrated levels of the pharmaceutical active(s). Specifically, these compositions for extended periods do not allow the active to precipitate or settle out of solution. Among the advantages of this invention is that the compositions do not require agitation/shaking prior to use as a method to re-suspend or dissolve active drug material to insure even and consistent dosing.
Patent AU-2002337307-B2 (AU)
Title: Data processing system and method
Inventor: PHILIPPE OLIVIER
IPC: G06F9/46
Filed: 2002-10-24
Granted: 2008-04-17
Abstract: An architecture suitable for running on processing systems of limited processing power is disclosed. The architecture facilitates the portability of applications and optimises the use of CPU and/or memory resources. The architecture is embodied in novel data structures and applications which may be compiled into an extremely low footprint and optimised machine code. Also disclosed are tools for developing applications and particular applications of the architecture. The invention is particularly useful in the context of set-top-boxes, where it facilitates production of interactive games and the like which were previously not practicable.
Patent AU-2003213431-B2 (AU)
Title: Method of bonding fluororesin films and fluororesin film
Inventor: TSUKADA TETSURO
IPC: B29C65/00
Filed: 2003-03-20
Granted: 2008-06-12
Abstract: A method for bonding fluororesin films, a wide fluororesin film obtained by the method, and a covering material for agricultural use, made thereof, are presented. A method of bonding films (A), wherein two sheets of films (A) made of a fluororesin, are disposed so that their edges overlap each other, a central part (b1) of the overlapping portion (B) is press-bonded under heating at a temperature within a range of from lower by 5 DEG C to higher by 20 DEG C than the melting point of the fluororesin, and then the entire area of the portion (B) is press-bonded at a temperature within a range of from lower by 30 DEG C to lower by more than 5 DEG C, than the melting point, to weld the two sheets of films (A); a wide fluororesin film obtained by the method; and a covering material for agricultural use, made thereof. <IMAGE>
Patent AU-2003264913-B2 (AU)
Title: Disposable intestinal intubator with drain and irrigator
Inventor: MATASOV SERGEY
IPC: A61M3/02
Filed: 2003-06-16
Granted: 2008-07-31
Abstract: The invention is intended for secure emptying of organism's cavities, particularly for colon decompression. The device combine the drain with means of its delivery in the shape of everting by fluid invaginator, comprising the drain, as well as their intractor. The secure emptying of cavity is ensured by a hose with punctures, placed in drain. The liquid, feeding into hose, realizes drain's recanalization, irrigates its holes and dilutes cavity contents. Transportation of drain into colon is ensured by synergy of two intubation forces. The vanguard force is generated by fluid pressure which everts invaginator, the rearguard (extraanal)-by "cylinder-piston" unit with a cuff. The hollow unit's piston acts as pneumatic carriage, but cuff is periodically joining with invaginator with drain or intractor. Evacuaton of contents is ensured by influx-and-extract method. The sequential connection of intractor and drain ensures not only intubation, but also contents' evacuation through both ends of drain. On the drawing is represented cecum with a distal fragment of drain-irrigation system of device: at left-in "evacuation" mode, at right-in "drain's recanalizaton-irrigation", "intestines irrigation" mode.
Patent AU-2003266253-B2 (AU)
Title: Method and computer system for handling incremental data in client-server communication
Inventor: MOSER MARTIN
IPC: G06F9/44
Filed: 2003-07-30
Granted: 2008-08-07
Abstract: A server-controller (101-1) on a server (901) receives (410) a modification-request generated by a client-controller (100-2) of a client (900) to modify an original model (200-T1) of an application component that is stored on the server (901) into a modified model (200-T2). A server-renderer (101-2) generates (420) at least one browser-increment (300-I) that corresponds to the difference between the original model (200-T1) and the modified model (200-T2). A client-assembler (100-1) receives the at least one browser-increment (300-I) from the server (901) and updates at the client (900) an original DOM component (300-T1) that corresponds to the original model (200-T1) with the at least one browser-increment (300-I), resulting in a modified DOM component (300-T2) that corresponds to the modified model (200-T2). <IMAGE>
Patent AU-2004221424-B2 (AU)
Title: A foldable, expandable framework for a variety of structural purposes
Inventor: KALNAY PETER A
IPC: F02F1/00
Filed: 2004-03-09
Granted: 2009-10-01
Abstract: Compacting, fully enclosed, floored combination multi-antechamber and ramp system for emergency and civil defense use providing, when expanded, means of ingress and egress for the general population including the infected, wounded and handicapped to and from buildings or other folding structures via portals to which its adapter may be securely attached or retrofit while passing through a series of two or more antechambers so as to prevent spreading contamination and allow for various decontamination protocols to be conducted in separate chambers. Compacting is achieved by modularity in some embodiments, and folding in other embodiments, in both framed and panel versions, providing important advantages for transport, pre-positioning, storage, and warehousing.
Patent AU-2005274540-B2 (AU)
Title: 1,5-diphenylpyrazoles
Inventor: HANS-MICHAEL EGGENWEILER
IPC: A61P35/00
Filed: 2005-07-14
Granted: 2011-06-30
Abstract: The invention relates to novel 1,5-diphenylpyrazole derivatives of formula (I), where R-R have the meanings given in claim 1, which are HSP90 inhibitors and which can be used for the production of a medicament for the treatment of diseases in which the inhibition, regulation and/or modulation of HSP90 plays a role.
Patent AU-2005298955-B2 (AU)
Title: Capsule with biasing sealing member
Inventor: GAVILLET GILLES
IPC: A47J31/40
Filed: 2005-10-20
Granted: 2012-01-19
Abstract: A capsule (1) for containing beverage ingredients is designed to be inserted in a beverage production device (2) in order to have water under pressure enter the capsule (1) in order to interact with the ingredients (3) in the capsule (1), wherein the capsule (1) comprises an base body (4) and a foil member (5) closing the base body (4) by being attached to a flange-like rim (6) extending from the side wall (7) of the base body (4) of the capsule (1). The capsule (1) thereby comprises a resiliently deflectable sealing member (8), the sealing member (8) being designed to be biased against a sealing surface (15) of the beverage production device (2), when the capsule (1) is positioned in the beverage production device (2). The sealing engagement of the sealing member of the capsule and the sealing surface is self-reinforcing when pressurized.
Patent AU-2005333454-B2 (AU)
Title: Coordination-polymeric triethanolamineperchlorato(triflato)metal inner complexes as additives for synthetic polymers
Inventor: WOLFGANG WEHNER
IPC: C08K5/00
Filed: 2005-06-23
Granted: 2011-09-22
Abstract: Disclosed is a stabilizer system for chlorine-containing polymers, particularly PVC, comprising at least one coordination polymeric triethanolamine perchlorato(triflato) metal inner complex containing a monomer unit of formula (A). Said stabilizer system can additionally contain substituted cyanoacetyl ureas or/and 6-aminouracils or/and 3-aminocrotonic ester or/and hydantoins or/and monomeric or polymeric dihydropyridines or alkaline earth hydroxides or/and hydrotalcites or/and dawsonites or/and zeolites or/and glycidyl compounds or/and cyanamides or/and cyanoguanidines or/and melamines. Phosphites or/and sterically hindered amines or/and NOR-HALS compounds can also be provided.
Patent AU-2006200866-B2 (AU)
Title: Methods and compositions for treating mammalian nerve tissue injuries
Inventor: SHI RIYI
IPC: A61F13/00
Filed: 2006-03-01
Granted: 2007-11-08
Abstract: To achieve, an in vivo repair of injured mammalian nerve tissue, an effective amount of a biomembrane fusion agent is administered to the injured nerve tissue. The application of the biomembrane fusion agent may be performed by directly contacting the agent with the nerve tissue at the site of the injury. Alternatively, the biomembrane fusion agent is delivered to the site of the injury through the blood supply after administration of the biomembrane fusion agent to the patient. The administration is preferably by parenteral administration including including intravascular, intramuscular, subcutaneous, or intraperitoneal injection of an effective quantity of the biomembrane fusion agent so that an effective amount is delivered to the site of the nerve tissue injury.
Patent AU-2006229982-B2 (AU)
Title: Container and method for containing and/or suppressing a fire
Inventor: BENJAMIN ARTHUR J
IPC: E05G1/024
Filed: 2006-03-23
Granted: 2012-08-16
Abstract: A container for containing and/or suppressing a fire may include a floor, a roof, and at least one wall associating the floor and the roof. The at least one wall may define an opening configured to provide access to the interior of the container. The container may further include at least one panel configured to close the opening. At least one of the floor, the roof, the at least one wall, and the at least one panel may include an intumescent material substantially covering an interior surface thereof.
Patent AU-2006233930-B2 (AU)
Title: Extremely insensitive detonating substance and method for its manufacture
Inventor: SOKOL-BARAK EDITH
IPC: C06B45/12
Filed: 2006-04-11
Granted: 2012-02-23
Abstract: The present invention provides an explosive composition of substantially reduced sensitivity and low f lammability, being definable as an extremely insensitive detonating substance (EIDS) according to UN Regulations for the Transport of Dangerous Goods and comprising one or more explosive material 42-58% vol. , one or more fire retardant material 15-26% vol. and a binder 20-36% vol.
Patent AU-2006273364-B2 (AU)
Title: Process for producing 1-benzyl-4-[(5,6-dimethoxy-1-indanone)-2-ylidene]methylpiperidine
Inventor: YUKIO NARABU
IPC: C07D211/32
Filed: 2006-07-24
Granted: 2011-08-04
Abstract: It is intended to provide a process for producing 1-benzyl-4-[(5,6-dimethoxy-1-indanone)-2-ylidene]methylpiperidine represented by the structural formula (I): (I) which is useful as an intermediate material for a pharmaceutical or a solvate thereof in which impurity content is further reduced and operation is simple and suitable for industrial production by reacting 5,6-dimethoxy-1-indanone with 1-benzyl-4-formylpiperidine in a reaction solvent in the presence of a base and then gradually crystallizing a target substance in a reaction mixture in a high temperature region.
Patent AU-2006304835-B2 (AU)
Title: CGRP peptide antagonists and conjugates
Inventor: MIRANDA LESLIE P
IPC: C07K14/585
Filed: 2006-10-20
Granted: 2011-09-15
Abstract: Disclosed is a composition of matter that involves a CGRP peptide antagonist. A pharmaceutical composition is disclosed that comprises the composition of matter and a pharmaceutically acceptable carrier, which can be configured for administration to a patient. Also disclosed is a method of producing the composition of matter. Methods of treating, preventing or mitigating migraine, are also disclosed.